LEA
BSX icon

Legacy Edge Advisors’s Boston Scientific BSX Stock Holding History

Legacy Edge Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,012
Closed -$287K – 225
2025
Q4 		$287K Buy
3,012
+30
+1% +$2.94K 0.03% 184
2025
Q3 		$291K Sell
2,982
-121
-4% -$12.5K 0.03% 172
2025
Q2 		$333K Buy
3,103
+94
+3% +$9.51K 0.04% 154
2025
Q1 		$304K Hold
3,009
– – 0.05% 146
2024
Q4 		$270K Buy
3,009
+255
+9% +$22.4K 0.04% 150
2024
Q3 		$231K Hold
2,754
– – 0.04% 170
2024
Q2 		$212K Buy
+2,754
New +$202K 0.04% 169

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Legacy Edge Advisors's BSX Position: Q1 2026 in Review

Legacy Edge Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,012 shares — an estimated $287K sold.

Legacy Edge Advisors first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $333K in Q2 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Legacy Edge Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Legacy Edge Advisors sold 3,012 Boston Scientific shares in Q1 2026, an estimated $287K.
  • Legacy Edge Advisors first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
  • Legacy Edge Advisors's Boston Scientific position peaked at $333K in Q2 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Legacy Edge Advisors's 13F filing for Q1 2026, filed 11 May 2026.